CLOVER HEALTH INVESTMENTS CORP CLA (CLOV) — insider trading
Health Care · NASDAQ
CLOVER HEALTH INVESTMENTS CORP CLA (CLOV) has 12 reported SEC Form 4 insider transactions in our data, including 11 open-market sales among the most recent 12 (latest 2026-07-08).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-08 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 2,384 | $4.68 | $11.2K | Form 4 |
| 2026-07-06 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 6,229 | $5.26 | $32.8K | Form 4 |
| 2026-07-01 | Toy Andrew | Director, Officer (Chief Executive Officer) | Open-market sale | 313,476 | $5.32 | $1.67M | Form 4 |
| 2026-06-17 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 2,360 | $4.78 | $11.3K | Form 4 |
| 2026-06-16 | OLDAKOWSKI JOSEPH FRANK | Officer (VP OF FINANCE AND CONTROLLER) | Open-market sale | 12,102 | $4.86 | $58.8K | Form 4 |
| 2026-06-15 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 6,350 | $4.61 | $29.3K | Form 4 |
| 2026-06-15 | Soares Karen | Officer (Chief Legal Officer) | Open-market sale | 4,681 | $4.61 | $21.6K | Form 4 |
| 2026-06-11 | Reynoso Jamie L. | Officer (CEO, Medicare Advantage) | Open-market sale | 7,289 | $4.91 | $35.8K | Form 4 |
| 2026-05-28 | Wai Conrad | Officer (CEO, Counterpart Health) | Open-market sale | 220,426 | $3.99 | $879.5K | Form 4 |
| 2026-05-18 | Edwards Carladenise Armbrister | Director | Open-market sale | 67,160 | $3.42 | $229.7K | Form 4 |
| 2026-05-16 | THORNTON JOSEPH CLAY | Officer (Interim CFO) | Shares withheld for taxes / exercise cost | 16,942 | $3.47 | $58.8K | Form 4 |
| 2026-05-13 | Priest Brady Patrick | Officer (CEO of Clover Care Services) | Open-market sale | 98,039 | $3.52 | $345.1K | Form 4 |
Ask the chat about CLOV's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CLOVER HEALTH INVESTMENTS CORP CLA (CLOV).
Last updated 2026-07-08 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.